Key terms
About SNOA
Sonoma Pharmaceuticals, Inc. engages in the development and production of hypochlorous acid (HOCl) products for wound care, animal health care, eye care, nasal care, oral care and dermatological conditions. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Boulder, CO.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest SNOA news
Apr 09
7:42am ET
Sonoma Pharmaceuticals Presents Business and Financial Update
Apr 04
7:42am ET
Sonoma Pharmaceuticals reports publication highlighting Microdox potential
Apr 02
7:42am ET
Sonoma Pharmaceuticals Outlines Growth and Challenges
Mar 27
7:42am ET
Sonoma Pharmaceuticals highlights safety advantages of microcyn products
Jan 23
7:38am ET
Sonoma Pharmaceuticals introduces Lumacyn Clarifying Mist
Jan 12
11:36am ET
Biotech Alert: Searches spiking for these stocks today
Jan 11
11:25am ET
Biotech Alert: Searches spiking for these stocks today
Jan 11
11:25am ET
Biotech Alert: Searches spiking for these stocks today
No recent news articles are available for SNOA
No recent press releases are available for SNOA
SNOA Financials
Key terms
Ad Feedback
SNOA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
SNOA Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
